Form 4: Akoya Biosciences Director Acquires 50,000 Stock Options

Robert G. Shepler, a director of Akoya Biosciences, Inc., acquired 50,000 stock options at an exercise price of $2.01 on June 4, 2024, which will vest on June 4, 2025, or the next annual meeting.

Summary

• On June 4, 2024, Robert G. Shepler, a director of Akoya Biosciences, Inc., acquired 50,000 stock options.
• The exercise price for these options is $2.01.
• The options vest in full on the earlier of June 4, 2025, or the date of the next annual meeting of Akoya Biosciences, Inc. after the grant date, subject to continuous service.
• The expiration date for these options is June 4, 2034.
• Following the transaction, Shepler directly owns 50,000 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of stock options by a director generally indicates confidence in the company's future, but it's a routine transaction.

Positives

• A director's acquisition of stock options can be seen as a positive signal, indicating confidence in the company's future performance.

Future Outlook

The vesting of the options is contingent upon the reporting person's continuous service through the vesting date, implying an expectation of continued involvement with the company.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, aligning the interests of management with those of shareholders.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for directors and executives in publicly traded companies, particularly in the biotech sector.
• The vesting schedule of one year is fairly typical, aligning with industry norms for incentivizing long-term commitment.
• The exercise price of $2.01 would need to be compared to the market price of Akoya Biosciences stock at the time of the grant to determine if it is at-the-money, in-the-money, or out-of-the-money, which would provide further context on the incentive provided.

Stakeholder Impact

• The acquisition of stock options by a director could have a slightly positive impact on shareholder sentiment.

Key Dates